Lianhua Qingwen capsule (granule) was approved as an additional indication of COVID-19

PR Newswire
April 15, 2020 — 05:55 CST

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!

Already have an account or paid subscription? Log in

Related Topics: Beijing brazil Canada China chinese coronavirus Covid-19 healthcare Hong Kong Indonesia medicine Mozambique patent pharmaceutical

Related News:

The 9th Asian Winter Games takes place

February 8, 2025 — 19:58

Vietnam Makes Top 5 Debut in Agoda’s 16th Gold Circle Awards, Celebrating Hospitality Excellence

January 28, 2025 — 11:00

Empowering Women Worldwide through Technology: #TCLforHer Wins the Prestigious Telly Award and Multiple International Marketing Honors

January 25, 2025 — 17:35

Altair Engineering Inc. Stockholders Approve Proposed Merger with Siemens

January 23, 2025 — 05:05

JSAUX Debuts at CES 2025, Showcases Innovative FlipGo Portable Monitor

January 5, 2025 — 12:00

Evolving Global Asset Management Industry in Focus at Asset Abu Dhabi

December 11, 2024 — 02:10

Crystal clear: Pingcheng period glassware of Northern Wei Dynasty

November 9, 2024 — 08:00

Harbour BioMed Announces Submission of IND Application for HBM9378/SKB378 in the Treatment of Chronic Obstructive Pulmonary Disease

November 8, 2024 — 17:45

LPS Launches NeuroNode: Empowering Advanced AI for Enterprises with On-Premises LLM

November 7, 2024 — 17:39

Franchising and Licensing Asia (FLAsia) 2024